Income Statement
INSIGHT MOLECULAR DIAGNOSTICS INC.
IMDX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
4.06 | 1.88 | 1.50 | 0.96 | 7.73 | 1.22 | - | - | - | - |
|
Cost of Revenue
|
1.75 | 1.05 | 1.00 | 0.88 | 4.19 | 1.86 | - | - | - | - |
|
Gross Profit
|
2.30 | 0.74 | 0.41 | -0.02 | 0.19 | -0.64 | - | - | - | - |
|
Operating Expenses
|
53.42 | 61.78 | 25.55 | 17.98 | 74.40 | 26.59 | 22.24 | 15.20 | 18.85 | 11.14 |
|
Research & Development
|
15.90 | 9.84 | 9.29 | 7.30 | 13.63 | 9.80 | 6.79 | 6.51 | 7.17 | 5.68 |
|
Selling, General & Administrative
|
10.63 | 10.20 | 11.18 | 21.88 | 22.34 | 16.79 | 13.28 | 7.01 | 9.23 | 5.46 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-51.12 | -61.04 | -25.14 | -18.00 | -74.21 | -27.23 | -22.24 | -15.20 | -18.85 | -11.14 |
|
Non-Operating Income
|
0.90 | 0.38 | 0.28 | -0.62 | 0.85 | -1.48 | -0.19 | -0.55 | -0.53 | -0.03 |
|
Interest Income
|
- | - | - | - | - | - | - | - | - | - |
|
Interest Expense
|
- | - | - | - | - | - | - | - | - | - |
|
Other Non-Op Income / Expense
|
1.01 | 0.46 | 0.39 | - | -0.27 | -1.55 | -0.28 | 0.09 | 0.00 | 0.00 |
|
Income Before Tax
|
50.20 | 60.70 | 24.90 | -18.61 | -73.36 | -31.19 | - | - | - | - |
|
Income Tax Expense
|
0.00 | - | 2.93 | 54.29 | -9.26 | -1.25 | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-50.22 | -60.66 | -27.78 | -72.90 | -64.10 | -29.93 | -22.43 | -15.75 | -19.38 | -11.17 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY |
|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-48.92 | -59.54 | -23.54 | -18.00 | -74.21 | -27.23 | -22.24 | -15.20 | -18.85 | -11.14 |
|
Earnings Per Share (Basic)
|
-1.65 | -4.66 | -3.75 | -0.66 | - | - | - | - | - | - |
|
Diluted EPS
|
-1.65 | -4.66 | -3.75 | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
30.48 | 13.07 | 7.65 | 0.11 | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
30.48 | 13.07 | 7.65 | - | - | - | - | - | - | - |
|
Comprehensive Income
|
-50.16 | -60.69 | -27.77 | -72.90 | -64.06 | -29.93 | -22.43 | -15.75 | -19.61 | -11.47 |